Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-11-20Clinical Trial Update: A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer [Phase 1]
A Phase 1 trial evaluating the combination of radium-223 dichloride with tasquinimod for bone-only metastatic castration-resistant prostate …
-
CLINICAL_TRIALS withdrawal · 2015-10-05Clinical Trial Update: Ipilimumab and GMCSF Immunotherapy for Prostate Cancer [Phase 2]
Phase 2 trial of ipilimumab with GM-CSF immunotherapy for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-23Clinical Trial Update: Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer [NA]
The clinical trial evaluating targeted biopsies and cytological imprints in prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-01Clinical Trial Update: STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling [Phase 2]
Phase 2 study of STA-9090 (ganetespib) in castration-resistant prostate cancer was withdrawn. The trial included assessment of androgen rece…
-
CLINICAL_TRIALS withdrawal · 2015-07-30Clinical Trial Update: Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology [NA]
Duke University's clinical trial evaluating circulating tumor cells in prostate cancer based on epithelial-mesenchymal transition biology ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-07-22Clinical Trial Update: Study of Metformin With Simvastatin for Men With Prostate Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating metformin with simvastatin for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) [EARLY_Phase 1]
This clinical trial evaluating onabotulinumtoxinA (BOTOX) for men with prostate cancer and lower urinary tract symptoms/benign prostatic hyp…
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer [Phase 2]
A Phase 2 trial evaluating the PET imaging agent [89]Zr-Df-IAb2M for high-risk prostate cancer has been withdrawn.
-
EMA withdrawal · 2015-05-19EMA Withdrawn: Provenge (autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor) — Dendreon UK Ltd
Dendreon’s Provenge has been withdrawn in Europe, with the therapeutic area listed as prostatic neoplasms.
-
CLINICAL_TRIALS withdrawal · 2015-04-07Clinical Trial Update: Blood for Immune Response to Provenge® in HRPC
Clinical trial evaluating blood-based immune response to Provenge in hormone-refractory prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer [Phase 1]
A Phase 1 feasibility and safety study of preoperative high-dose single-fraction image-guided radiotherapy before radical prostatectomy in m…
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer [Phase 2]
A phase 2 trial of sorafenib for hormone-naïve biochemical recurrence of prostate cancer was withdrawn, with no results reported.
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating dorsal penile block to alleviate Foley catheter discomfort after robotic prostatectomy has been withdr…
-
CLINICAL_TRIALS withdrawal · 2015-01-26Clinical Trial Update: A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy [Phase 2]
A Phase II neoadjuvant study of enzalutamide, abiraterone acetate, dutasteride, and degarelix in men with localized prostate cancer was with…
-
CLINICAL_TRIALS withdrawal · 2015-01-19Clinical Trial Update: A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT [Phase 2]
A phase 2 clinical trial evaluating dovitinib in combination with androgen deprivation therapy for metastatic prostate cancer has been withd…
-
CLINICAL_TRIALS withdrawal · 2014-12-08Clinical Trial Update: Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management
A clinical trial evaluating active surveillance with or without MRI-guided management for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-10-23Clinical Trial Update: 18-F-Fluoroacetate as PET Imaging Agent [Phase 1]
A Phase 1 trial of the PET imaging agent 18-F-Fluoroacetate sponsored by MD Anderson Cancer Center was withdrawn, with conditions including …
-
CLINICAL_TRIALS withdrawal · 2014-07-29Clinical Trial Update: Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer [NA]
A clinical trial evaluating imaging during surgery to diagnose prostate, bladder, or kidney cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-23Clinical Trial Update: Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Phase Ib/II trial evaluating orteronel with itraconazole in men with castration-resistant prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-04-10Clinical Trial Update: MR-Guided Laser Ablation of Prostate Bed Recurrences [NA]
The Mayo Clinic-sponsored trial evaluating MR-guided laser ablation for prostate bed recurrences has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-19Clinical Trial Update: The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation [Phase 1]
The JET Study, a Phase I trial of cabazitaxel with radiotherapy and long-term androgen deprivation for prostate cancer, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-11Clinical Trial Update: Study of POMELLA™ Extract to Treat Prostate Cancer [NA]
A clinical trial of POMELLA™ Extract for prostate cancer has been terminated; no results are provided in this update.
-
CLINICAL_TRIALS withdrawal · 2014-02-12Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating stereotactic body radiotherapy with concurrent boost for low- and intermediate-risk prostate cancer has been withdr…
-
EMA withdrawal · 2014-01-21EMA Lapsed: Docetaxel Teva Pharma (docetaxel) — Teva Pharma B.V.
The EMA lists Docetaxel Teva Pharma as lapsed (withdrawn) for multiple indications including non-small cell lung carcinoma, breast neoplasms…
-
CLINICAL_TRIALS withdrawal · 2014-01-14Clinical Trial Update: Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating conversion to sirolimus versus reduction of calcineurin inhibitors in renal transplant patients with p…